Results 81 to 90 of about 167,517,803 (126)

Architects of folding, editors of immunity: the strategic use of <i>N</i>-glycans in vaccine design. [PDF]

open access: yesFront Immunol
Orioli S   +3 more
europepmc   +1 more source

Unmasking genetic etiologies in neurodevelopmental disorders characterized by Cerebral Palsy: insights from integrative genomic approaches. [PDF]

open access: yesFront Neurol
Yigit A   +13 more
europepmc   +1 more source

Tofacitinib Improves Motor Symptoms in Parkinsonism Associated with a Heterozygous NGLY1 Variant and Autoimmune Disease. [PDF]

open access: yesEur J Case Rep Intern Med
Reina-Llompart N   +3 more
europepmc   +1 more source

Dynamic glycosylation remodeling in neurological disorders. [PDF]

open access: yesFront Mol Neurosci
Xing D   +6 more
europepmc   +1 more source

TUSC3 serves as a rate-limiting gatekeeper of a glycan-mediated ER triage checkpoint for BMP4/Dpp. [PDF]

open access: yesCell Rep
Galeone A   +9 more
europepmc   +1 more source

Expanding carrier screening: beyond the genes, to include underrepresented ancestries. [PDF]

open access: yesNPJ Genom Med
Bylstra Y   +12 more
europepmc   +1 more source

Home - About - Disclaimer - Privacy